A Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB086550 in Participants With Advanced Solid Tumors
Clinical trial NCT03762447 · COMPLETED
Trial details
- NCT number
- NCT03762447
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-10
- Primary completion
- 2023-11-17
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.